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Mammalian stanniocalcin-1 (STC-1) is one of several ligands targeted to mitochondria. High aﬃnity STC-1 receptors are present
on the mitochondrial membranes of nephron cells, myocytes, and hepatocytes, to enable ligand sequestration within the matrix.
However, STC-1 receptors have not been characterized in ﬁsh. Nor is it known if mitochondrial targeting occurs in ﬁsh. The aim
of the study was to address these questions. Saturation binding assays were carried out to obtain estimates of KD and Bmax. They
revealed the presence of saturable, high-aﬃnity receptors on both membranes and mitochondria of liver, muscle, and gill ﬁlament.
In situ ligand binding (ISLB) was used to localize receptors at the histological level and revealed some unexpected ﬁndings. In
cranium, for instance, receptors were found mainly in the cartilage matrix, as opposed to the chondrocytes. In brain, the majority
of receptors were located on neuropil areas as opposed to neuronal cell bodies. In skeletal muscle, receptors were conﬁned to
periodic striations, tentatively identiﬁed as the Z lines. Receptors were even found on STC-1 producing corpuscles of Stannius
cells, raising the possibility of there being an autocrine feedback loop or, perhaps, a soluble binding protein that is released with
the ligand to regulate its bioavailability.
1.Introduction
Although stannniocalcin-1 (STC-1) was originally described
in ﬁsh, it is now known to be present throughout the
animal kingdom in both vertebrates and invertebrates [1].
The principle source of STC-1 in bony ﬁsh are endocrine
glands known as the corpuscles of Stannius (CS) which
are anatomically associated with the kidneys. STC-1 release
is stimulated by a rise in serum levels of ionic calcium
above the physiological set point through the activation
of calcium-sensing receptors. The hormone then exerts
regulatory eﬀects on the epithelial transport of calcium
and/or phosphate across the gills, gut, and kidneys in order
to restore normocalcemia [2].
There is also long-standing evidence that the CS glands
play a broader role in regulating extracellular ﬂuid (ECF)
balance.Some of the earliest studies described how surgically
removing the CS glands caused perturbations in serum
levels of sodium and potassium, not just calcium [3].
Early studies also described how the glands contained a
substance with vasopressor eﬀects in both mammals and
ﬁsh [4]. More recent studies have shown that hypovolemia
is a potent stimulus for STC-1 secretion in ﬁsh [5] and,
equally intriguingly, that the renin-angiotensin response to
hypovolemia is attenuated in ﬁsh lacking STC-1 [6].
It is also now recognized that STC-1 production is
not conﬁned to the CS glands [7–10]. Indeed the gene
is variably expressed at much lower levels in most organ
systems. In rainbow trout, the highest levels of expression
outside the CS glands are in the male and female gonads
and the anterior region of the kidney, commonly known
as head kidney [4]. In ﬂounder, Platichthys ﬂesus,h o w e v e r ,
the caudal neurosecretory system has the highest levels of
gene expression outside the CS glands [7]. Interestingly, the
gene product in these other tissues is not necessarily the
same as that in the CS glands. For instance a more heavily2 ISRN Endocrinology
glycosylated variant is produced by the ovaries in female
rainbowtrout[11].Thefunctionofthisoocyte-derivedSTC-
1 has not yet been addressed, but it may act locally in oocyte
development and is possibly released into the circulation.
As in the case of mammals, a second form of STC, STC-
2, has also been identiﬁed in ﬁsh. In the Japanese ﬂounder,
STC-2 has the same broad tissue distribution as STC-1 [12].
The functions of ﬁsh STC-2 have yet to be identiﬁed, but the
limited data that is currently available suggests that, unlike
STC-1,itdoes not modulatethe movementofcalciumacross
the ﬁsh gill [2].
The studies to date on mammalian STC-1 receptors have
led to important advances in our understanding of both
ligand targeting and function [13–16]. One of the most
intriguing discoveries relates to manner in which STC-1 is
sequestered by target cell organelles in what appears to be
a receptor-mediated process. Depending on the tissue type,
these organelles so far include the lipid storage droplets of
adipocytes and steroidogenic cells[15,16],the mitochondria
of hepatocytes, skeletal myocytes, and nephron epithelial
cells [14], and the nuclei of milk-producing mammary gland
alveolar cells [13, 17]. Very little is known at present about
the signal transduction and targeting pathways employed
by STC-1 in ﬁshes or if ligand sequestration takes place in
this vertebrate class as it does in mammals. Therefore, the
purpose of this study was to characterize STC-1 receptors
in ﬁsh tissues in terms of KD and Bmax. We also sought
to determine if ﬁsh receptors were found on mitochondria
as they are in mammals. Finally, we sought to localize the
receptors at the histological level, using freshwater rainbow
trout as a model system.
2.MaterialandMethods
2.1. Animals and Tissue Preparation. Fingerling (0.5–1.0g)
and adult (200–300g) rainbow trout were obtained from the
Rainbow Springs Trout Farm in Thamesford, ON, Canda.
Animals were euthanized in benzocaine dissolved in tank
water for harvesting and ﬁxation of tissues. Whole ﬁngerling
trout and tissues from adult trout were immersed in 4%
paraformaldehyde and buﬀered to pH 7.4 with 50mM
sodium phosphate. The abdominal cavities of ﬁngerlings
wereopenedwithascalpelbladepriortotheﬁxationprocess.
Seawater-adaptedAtlanticsalmonkidneysbearingCSglands
were obtained on arrival at the Brown’s Bay Fish Packing
Plant (Campbell River, BC, Canada) and placed immediately
in ice-cold ﬁxative. All tissues were then dehydrated and
embedded in paraﬃn. Five-micron tissue sections were cut
and mounted on microscope slides in preparation for local-
izing STC-1 protein and receptor by immunocytochemistry
and in situ ligand binding, respectively.
2.2. Receptor Binding Studies. Because recombinant human
STC-1 (hSTC-1) is biologically active in rainbow trout [18],
receptor binding studies were carried out using a fusion
protein of human STC-1 and heat-stable human placental
alkalinephosphatase(STC-AP).Theuseofafusionproteinis
necessitated by the poor binding characteristics of radioiodi-
nated STC-1 [14]. The fusion protein has been characterized
for speciﬁcity in ﬁxed and embedded mammalian tissues
by in situ ligand binding and in saturation binding assays
on membranes, cell nuclei [13], cholesterol lipid storage
droplets [15, 16], and both mitoplasts and mitochondria
[14].
Saturation Binding Assays. Estimates of receptor KD and
Bmax were obtained in liver, kidney, gill, and white epaxial
muscle. Each tissue was dissected from three adult trout and
pooled. In the case of the gills, ﬁlaments were gently scraped
with a scalpel blade to separate the soft tissue comprising the
respiratory and transporting epithelia from the cartilaginous
ﬁlaments. All tissues were fractionated by Dounce’s homog-
enization and diﬀerential centrifugation for the isolation
of microsomal membranes and mitochondria as previously
described [14]. The relative purity of each subcellular
fraction was determined using 5 -nucleotidase and succinate
dehydrogenase assays as representative markers of plasma
membrane and mitochondria as previously described [11].
Saturation binding assays were carried out on micro-
somal membranes and mitochondria from gill, liver, and
muscle for estimations of KD and Bmax [14]. To set up
an assay, aliquots of 50–100 micrograms of membrane or
mitochondrial protein were added to 1.5mL Eppendorf
tubes followed by increasing amounts of STC-AP ± 1μM
recombinant hSTC-1 (all determinations were done in trip-
licate). Following a 90min incubation at room temperature
under constant agitation, tubes were centrifuged to pellet the
membranes or mitochondria. The pellets were washed and
then heat treated at 65◦ for 30min to destroy endogenous
AP activity. The separation of bound and free ligand,
subsequent detection of AP activity, and calculations of
speciﬁc binding were performed as already described [13, 14,
19]. Saturation binding curves were analyzed in GraphPad
Prism (GraphPad Software Inc., San Diego, CA, USA) using
a nonlinear regression analysis of one site binding to obtain
best estimates of KD and Bmax. GraphPad was also used to
obtain negative reciprocal Scatchard plots.
InSituLigandBindingStudies. TolocalizeSTC-1receptorsat
the histological level, in situ ligand binding (ISLB) was per-
formed as previously described [13–15, 19]. Hydrated tissue
sectionswereincubatedfor90minutesina10nMsolutionof
STC-AP.Controltissuesectionswereincubatedinequivalent
amounts of recombinant human alkaline phosphatase (AP),
also generated in MDCK cells or STC-AP plus 1μMh u m a n
STC-1 or 1μMs a l m o nS T C - 1 .I ns o m ec a s e s ,a d j a c e n t
tissue sections were stained with hematoxylin and eosin. Six
ﬁngerling trout and 3 Atlantic salmon were analyzed in this
manner, and all tissue sections were evaluated by 3 diﬀerent
examiners.
2.3. Immunocytochemistry. Immunocytochemistry (ICC)
was performed in select cases to determine if the distribution
of STC-1 ligand corresponded with that of the receptor. ICC
was done as previously described using a salmon polyclonal
STC antiserum already characterized for speciﬁcity [8, 20–
22]. Tissue sections were incubated overnight at 4◦C
with a 1:1000 dilution of rabbit antiserum. The sitesISRN Endocrinology 3
of antibody binding were visualized with biotinylated
secondary antibodies and the Vectastain ABC peroxidase
detection system (Vector Laboratories, Burlingame, CA,
USA). As staining controls, tissue sections were incubated
in antiserum preabsorbed with salmon STC-1 (1μg/mL).
All ISLB and ICC images were captured on a Nikon E1000
upright brightﬁeld microscope (Nikon Canada, Mississauga,
ON, Canada) with a DXM1200 digital camera and ACT-1
software (Nikon Canada, Mississauga, ON, Canada).
3. Results
Saturation binding studies were carried out on isolated
microsomal membrane and mitochondrial preparations
from three diﬀerent tissues; liver, epaxial muscle, and the soft
tissue component of the gill ﬁlament. In each instance, high-
aﬃnity and saturable binding sites were identiﬁed in both
subcellular fractions (Figure 1). In mitochondria, binding
capacity was highest in liver (36pmol/mg protein) and
equally low in muscle (0.7pmol) and gill (0.6pmol). Sim-
ilarly, microsomal membrane binding capacity was highest
in liver (6.4pmol/mg) and 10-fold lower in muscle and
gill (Figure 1). The binding aﬃnities of liver microsomal
membranes and mitochondria (3.2–3.7nM) were lower
than those on muscle and gill (0.7–1.9nM) but would
in all instances be classiﬁed as high-aﬃnity binding sites,
as beﬁtting the concentrations of circulation STC-1 (0.1–
5.0nM) in ﬁsh serum (33–35).
In situ ligand binding (ISLB) studies revealed the
presence of speciﬁc, STC-1 binding sites in most tissues
and/or organs. These included brain, cartilage, adipocytes,
skeletal, cardiac and visceral smooth muscle, liver, kidney,
gastrointestinal tract, the eye, and the teeth.
Figure 2A shows the distribution of binding sites in the
snout of a ﬁngerling trout. The diﬀerent shades of staining
obtained by ISLB are indicative of binding density; brown
representing the lowest number of binding sites, purple
being intermediate, and blue-black being the highest. Of
all the tissue types comprising the snout, the underlying
cartilage (C) of the developing cranium exhibited the most
intense binding activity. In the specimen shown, binding
activity was most intense in the regions bordering the brain
(Figure 2A). At higher magniﬁcation, however (Figure 2B),
it was evident that the majority of STC-1 binding sites were
not in chondrocytes, but rather the surrounding matrix
(Figure 2B). The degree of cranial binding activity varied
greatly throughout the cranium and among individual ﬁsh
(compare Figures 2Aa n d2C). The same was true in the case
of the appendicular skeleton (not shown). Skeletal muscle
ﬁbres within the snout also exhibited strong binding activity,
as did nerve ﬁbres within the forebrain (Figure 2A). The
binding of STC-AP was abolished with the inclusion of
recombinant hSTC-1 in the incubation (Figure 2A inset).
Figure 2C through 2G in Figure 2 show the distribution
of STC-1 binding sites in the alimentary canal, beginning
with the buccal cavity. In the buccal cavity (Figure 2C), the
epithelialliningandunderlyingmuscularismucosaexhibited
moderate binding activity. Of particular note were the devel-
oping teeth where strong binding activity was apparent in
the dentine layer. In contrast, the underlying pulp exhibited
little or no binding activity (inset in Figure2C). The mucosal
epithelium lining the buccal cavity was primarily made up of
goblet cells, all of which exhibited moderate binding in their
basolateral surfaces (Figure 2D), whereas the underlying
submucosa exhibited weak binding. By far the highest
binding was observed over visceral smooth muscle cells
comprising the underlying muscularis mucosa (Figure 2D).
The same pattern of receptor binding activity was apparent
in the esophagus (Figure 2E) and particularly in the stomach
(Figure 2F), where the more highly developed muscularis
mucosa exhibited the strongest binding activity. Only in the
small intestine did mucosal epithelial cells begin to show
signiﬁcant binding activity (Figure 2G). Overall, therefore,
binding activity in the alimentary canal was highest in
visceral smooth muscle cells (muscularis mucosa) in all
segments anterior to and including the stomach.
Red blood cells exhibited some of the most intense
binding activity (Figure 2H). In all cases the cell nucleus
was negative as compared to the cytoplasm where binding
was evenly distributed throughout. In all specimens and age
classes, the majority of erythrocytes (>80%) were stained in
this manner.
Within the ovary, the cytoplasm of previtellogenic
oocytes in particular displayed high binding activity (Fig-
ure 2I). Oocyte nuclei exhibited little binding activity by
comparison. With each stage of maturation, the degree of
binding within the cytoplasm decreased markedly, such that
in vitellogenic stage the majority of receptors were conﬁned
to the center of the oocyte. Binding was also evident in the
surrounding theca and granulosa cell layers of vitellogenic
oocytes. STC-AP binding to these ovarian cell types was
reduced markedly by the inclusion of recombinant hSTC-1
(Figure 2I inset).
As inthe caseofvisceralsmooth muscle,therewasstrong
binding to cardiac myocytes, but less so to liver hepatocytes
(Figure 2J).
Figure 3 shows the distribution of STC binding sites
in a representative region of the brain and a cross-section
through the eye of a ﬁngerling trout. Figures 3Aa n d3B
show adjacent sagittal sections through the right side of
the brain encompassing the optic tectum overlying the
mesencephalic ventricle and stained for receptors (A) and
with haematoxylin-eosin (B), respectively. The general trend
revealed by comparing the two sections is that receptor
binding activity is highest in regions composed primarily
of neuropil (pink in (B)) and lowest in regions rich in
cell perikarya (dark blue in (B)). Optic tectum, which had
the highest binding activity, is a case in point. The layers
made up almost entirely of neuropil and ﬁbres exhibited
the highest binding activity (between stratum marginale and
stratum album centrale in Figures A and C). In comparison,
the inner layer of optic tectum comprised entirely of cell
bodies and their nuclei exhibited little or no binding activity
(stratumperiventriculareinAandC).Exactlythesametrend
was evident outside the optic tectum, where strong binding
activity was observed over neuropil-rich regions and nerve
tracts comprising the granular eminence of the cerebellum
(C), midbrain (M), diencephalon (D), telencephalon (T),4 ISRN Endocrinology
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Figure 1: Receptor binding assays on muscle, liver, and gill. Saturation binding assays revealed the presence of saturable, high-aﬃnity
binding sites on microsomal membrane and mitochondria fractions from liver, muscle, and gill tissue from adult trout. Liver membranes
and mitochondria had the highest binding capacities and lowest aﬃnities, whereas the data for muscle and gill were similar. Each data point
shown represents the mean ± SEM of three replicates. Each binding assay was repeated three times. The Bmax and KD values listed in each
panel are those estimated from the saturation binding curves. Scatchard plots derived from the saturation binding data are shown as insets
in each panel.ISRN Endocrinology 5
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Figure 2: ISLB staining of snout, alimentary canal, erythrocytes, ovary, and heart. (A), Snout; STC-1 binding sites in the snout are most
prominent in cranial cartilage (c), the inset at the lower left is a staining control; (b), brain olfactory bulb; skm, skeletal muscle. (B), higher
magniﬁcation of smaller boxed area in (A) showing intense binding activity conﬁned to the matrix surrounding lacuna-bound chondrocytes
(∗). (C), tissue section adjacent to larger boxed area in (A), stained by ICC for STC-1 protein. In cranial cartilage (c), STC-1 is present in
both chondrocytes and the surrounding matrix. High immunoreactivity is also present in skin (s). (D), Buccal cavity; binding sites are most
evident in the mucosal (m) layer of cells lining the mouth and emerging teeth (∗), the boxed area shows a magniﬁed tooth (∗) with high
binding activity (red arrows) in the dentine layer (bc, buccal cavity; s, skin; p, pigment layer). (E), esophagus; weak binding is present in the
mucosal (m) and sub-mucosal (sm) layers of the esophagus. Muscularis mucosa (mm) exhibits the highest binding activity. (F), stomach;
binding is lowest in mucosa (m) and highest in the underlying muscularis mucosa (mm) at the junction of the cardiac (c) and pyloric (c)
regions of the stomach. (G), small intestine; binding is highest in mucosal enterocytes (m) and muscularis mucosa (mm) and lowest in
the submucosa (sm). (H), red blood cells; most erythrocytes contain high binding activity that is conﬁned to the cytoplasm. (I), ovary, the
highest binding is conﬁned to the cytoplasm of primary oocytes (po). Weaker binding is evident in theca cell (tl), granulosa cell layers (gl),
and cytoplasm of vitellogenic oocytes (vo). The inset at the lower left is a staining control. (J), heart (h); all cardiac myocytes exhibited high
binding activity as did surrounding skeletal myocytes (skm). Lower binding was present in liver (l) hepatocytes.6 ISRN Endocrinology
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Figure 3: ISLB staining of brain, eye and scale. (A)–(D) Brain; adjacent sagittal sections through the trout fry head stained by ISLB for
receptors (A) or with hematoxylin & eosin (B). Binding is highest in regions of the brain comprising neuropil areas and nerve tracts (pink)
and lowest in areas comprising neuronal cell bodies (blue). The boxed areas in (A) and (B) are magniﬁed in (C) and (D), respectively.
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opticum, ﬁbrosum, griseum, and album centrale. In contrast, relatively weak binding was present over cell bodies in the ventral aspect of
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∗) is a tissue section adjacent to (C), stained by ICC for STC-1
protein. Most of the STC-1 immunoreactivity is over neuropil and nerve tracts in the inner aspect of optic tectum. (E) and (F), Eye; adjacent
sections through the trout fry eye stained with hematoxylin & eosin (top in E) or by ISLB for receptors (bottom in E). The boxed areas in
(E) are magniﬁed in (F). Binding is highest in the neuropil layers—inner plexiform (IP) and outer plexiform (OP), nerve ﬁber (NF), rods
and cones (RC)—and weakest in layers comprising small cell bodies—inner nuclear (IN) and outer nuclear (ON). Other abbreviations; C;
chondrocyte; NF, nerve ﬁbre layer; PL, pigment layer. (G). Scale; strong ISLB staining is evident over radii in the anterior (yellow arrows;
right) and posterior ﬁelds (red arrow; left).ISRN Endocrinology 7
and the optic nerve (ON), while weaker binding was seen
over zones rich in cell bodies. For this reason, the inferior
lobe of the hypothalamus (H) stood out on account of
having weak binding activity, but this was only due to the
high concentration of cell nuclei in this particular tissue
section.
Figures C and D in Figure 3 are higher magniﬁcations
of the optic tectum, stained for receptors and haematoxylin
eosin, respectively. Within the optic tectum, neuropil and
ﬁbre regions comprising the strata marginale and opticum,
strata ﬁbrosum and griseum superﬁciale, as well as the
strata griseum central, and album central, exhibited intense
binding activity. It was diﬃcult to determine if binding
sites were similarly present on the neuronal cell bodies
(fewer in number) in these same strata. Strong binding
activitywasevident,however,oncellbodiesintheoutermost
aspect of the stratum periventriculare and in the ependymal
layer. These receptor-positive cells in both zones also had
in common a strong degree of eosinophilia, indicative of
neuropil and ﬁbre regions.
Theskinoverlyingthecraniumexhibitedmoderatelevels
of binding activity, speciﬁcally the cytoplasm of mucous-
secreting cells, whereas little or no binding was evident in the
dermis or the cartilaginous cranium (Figure 3C).
Figures 3Ea n d3F are a cross-section through the
ﬁngerling eye, stained with either STC-AP or haematoxylin-
eosin and photographed at low (E) and high magniﬁcation
(F). There was no receptor binding activity of note in the
lens or cornea. Binding activity was conﬁned for the most
part to rods and cones (RC), the outer plexiform (OP),
inner plexiform (IP), and nerve ﬁber (NF) layers. Some
inner nuclear (IN) layer cells also showed clear binding
activity. The cytoplasm of all chondrocytes (C) within the
cartilaginous optic capsule was receptor positive, as was
that of cells comprising the outer epithelial capsule. Finally,
Figure 3G shows a single ctenoid-type scale from a ﬁnger-
ling trout where strong binding activity is evident in the
radii.
Figure 4A is a sagittal section through the anterior trunk
of a ﬁngerling and stained for receptors. As in the case
of skeletal muscle elsewhere, binding activity was highest
in the epaxial musculature. At higher magniﬁcation it was
evident that this binding was conﬁned to regularly spaced
striations that spanned the sarcomere at intervals of ∼
1.5 microns (Figure 4B). Correlative ICC staining revealed
that STC-1 protein was similarly sited over the striations
(Figure 4B; inset). The cartilaginous neural spines of the
vertebral column that protruded into the epaxial muscula-
ture were comparatively devoid of binding activity, as was
the cartilage comprising each vertebral body (Figure 4A).
However, weak binding was present in the underlying stro-
mal adipocytes and skeletogenic layer of cells coating each
vertebral body. In addition, like the nerve tracts throughout
the brain, those in the spinal cord contained binding activity
(Figure 4A).
Nephron epithelial cells were generally receptor-positive
in both the anterior and posterior portions of the kidney.
The one notable exception was newly developing nephron
segments, which were receptor-negative (Figure 4C). For
comparative purposes, kidney tissue was also examined
from a seawater-adapted salmonid, the Atlantic salmon.
Developing nephron segments were not found in adult
salmon, and all tubule types proved to be receptor-positive.
Furthermore,asinfreshwatertrout,hematopoietictissuewas
generally devoid of binding activity. Intriguingly, however,
whereas receptor binding was conﬁned to the cytoplasm of
mostnephroncelltypes,bothnuclearandcytoplasmbinding
activity were clearly evident in salmon collecting duct cells
(Figure 4D).
Unexpectedly, there was low, albeit signiﬁcant, binding
activity in STC-1 producing cells from the corpuscle of
Stannius of both salmon and trout. Whereas all CS cells
exhibited a low level of binding activity (Figure 4E ) ,as u b -
set of cells in most lobules displayed a visibly higher level of
binding (Figure 4F).
Finally, an examination of gill ﬁlament revealed the
presence of intense binding activity on a group of cells
that were highly reminiscent of chloride cells in terms of
their larger size and location on secondary lamellae. Ligand
binding to these cells was exclusively over the cytoplasm
(Figure 4G).
4. Discussion
Previous studies have demonstrated that the STC-1 gene is
widely expressed in ﬁsh, in tissues other than the CS glands
[7–10].Thepresentreporthasnowrevealedthatthereceptor
is as widely distributed as the ligand and that they likely
mediate paracrine and autocrine signalling in a wide range
of tissues. However, which tissues are targeted exclusively by
blood-borne versus locally produced ligand still needs to be
established.
STC-1 receptors have, thus far, been described in mam-
mals, and leeches [2]. In both cases the receptors and/or
binding sites were saturable and had reported aﬃnities in
the low nM range depending on tissue and organelle type.
Leech receptors have a somewhat lower aﬃnity with a KD
in the 10nM range [2]. The ﬁsh receptor likewise proved
to be saturable, had aﬃnities that fell well within the range
of those reported in mammals and was found to be present
on both microsomal membranes and mitochondria. The
latter ﬁnding in particular is compelling evidence that the
ﬁsh ligand targets the mitochondrial compartment, at the
very least in hepatocytes, myocytes, and gill ﬁlament cells.
However, the number of cell types targeted in this manner is
likely to be considerably larger.
As in the case of many polypeptide hormones, STC-1
has diﬀerent eﬀects on diﬀerent cell types [2, 17, 23, 24].
Thus, it is not altogether surprising that it is targeted to
a wide range of cell and tissue types. Moreover, where a
receptor is located can often be indicative as to function. In
ﬁsh cartilage, for instance, the STC-1 gene is expressed in
chondrocytes [8]. However, in the present study, the receptor
was preferentially sited in the cartilage matrix, with much
lower levels being found in nearby chondrocytes. Correlative
immunocytochemical staining showed that the ligand was
present in both chondrocytes (the site of synthesis) and
matrix. Thus, it would appear that STC-1 receptors are8 ISRN Endocrinology
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Figure 4: ISLB staining of trunk, muscle, kidney, corpuscle of Stannius, and gill. (A) Dorsoanterior trunk; this sagittal section shows that the
highest ISLB staining is over epaxial skeletal muscle (skm), followed by spinal cord (sc), nephron (n), and the outer muscularis layer in swim
bladder (sb). Hematopoietic tissue (h) within the kidney (k) exhibits weak binding activity. Other abbreviations; s, stromal adipocytes; vb,
vertebral body. (B) Skeletal muscle; at high magniﬁcation it is evident that STC-1 binding is present over regularly spaced striations that are
reminiscent of Z lines (1.5μM between the red arrows). The inset in panel (B) is an adjacent section stained by ICC, showing STC-1 protein
sitedoverthesameregularlyspacedstriations.(C)Developingkidneytubule;adjacentsectionsstainedbyISLB(top)orhematoxylin&eosin
(bottom) reveal a collecting duct (cd) and a developing kidney tubule (yellow asterisk). ISLB staining is evident over collecting ducts but not
developing tubules. (D) Atlantic salmon collecting duct; STC-1 binding sites are evident in both the cytoplasm and nuclei (red arrow in D)
of collecting duct cells (cd), in contrast to distal tubule cells where binding is cytoplasmic and not nuclear (red arrow in D1). (E) Atlantic
salmon corpuscle of Stannius (CS; left) and adjacent kidney tissue (right); binding is strongest to kidney tubules and weaker over STC-1
cells of CS gland (deﬁned by black arrows). Abbreviations: cd; collecting duct; g, glomerulus. (F), Atlantic salmon corpuscle of Stannius
(CS) in panel (E) at higher magniﬁcation; ISLB staining is highest in red blood cells (black arrows). Staining is also evident over individual
cells comprising the CS lobule (red arrows). (G) Gill ﬁlament; binding activity is highest in the cytoplasm of isolated cells on and between
the primary lamella (red arrows). Staining was absent over ﬁlament cartilage (c) and weak elsewhere. The inset at lower right is a staining
control.ISRN Endocrinology 9
tetheringSTC-1ligandwithinthecartilagematrix,ascenario
that is highly reminiscent of TBG-β and the means of its
storage in mammalian bone. TBG-β is deposited within the
bone matrix tethered to latent TGF-β binding protein. When
the ligand is subsequently liberated during osteoclastic bone
resorption, it then attenuates further osteoclast activity [25].
As in all vertebrates, matrix remodelling is a requisite feature
of ﬁsh growth and development. Hence, it is possible that
the STC-1 sequestered within the matrix has a regulatory
role in the remodelling process, perhaps by acting back on
chondrocytes in an autocrine feedback loop. This certainly
appears to be the case in mammals. The mammalian STC-
1 gene is similarly expressed in chondrocytes. And yet
in cultured rat metatarsals, additions of STC-1 attenuate
growth plate development by slowing chondrocyte growth
and matrix synthesis [24]. Similarly, STC-1 overexpression
in transgenic mice delays skeletal development and cranial
suture closure [23]. Hence, there is already good evidence
in mammals of roles for STC-1 in cartilage and cranial
development. The absence of a bone phenotype in STC-
1 null mice, which was somewhat unexpected, is likely
indicative of redundancies in these critical developmental
pathways [26]. And, from a comparative perspective, there
may be functional signiﬁcance to the fact that STC-1 and
its receptor in mammalian cartilage are preferentially sited
in chondrocytes [24], as opposed to the surrounding matrix
as in ﬁshes.
Inthecaseofneuraltissues,suchasthebrain,spinalcord,
and eye, the majority of STC-1 receptors were associated
with nerve tracts rather than cell bodies. Most notable of the
brain regions examined was the heavy staining over neuropil
and ﬁbre areas comprising the optic tectum, the main visual
center. The selective targeting of STC-1 to these areas could
be reﬂective of any number of roles. For instance, STC-
1 has proven to be cytoprotective in mammalian neurons
exposed to hypoxia, in part by increasing cellular phosphate
uptake and reducing cytosolic calcium levels [27]. As such,
thehormonecouldeasilybeactingasanantiapoptotic agent.
Alternatively, through its eﬀects on mitochondrial calcium
uniport activity STC-1 could be regulating cytosolic calcium
levels as a means of controlling neuronal excitability. More
detailed studies on the ﬁsh brain are clearly warranted by
the present ﬁndings. They are justiﬁed more so by a second
major diﬀerence in mammalian and piscine receptors,
namely, in their distribution patterns on neuronal cells. In
the regions of mammalian brain analyzed to date, the large
majority of STC-1 receptors are on the neuronal cell bodies
and not their nerve tracts [28]. It is possible, however,
that the receptor distribution in the brains of trout fry will
become more “mammalian-like” upon adulthood and that
the dissimilarities between mammals and ﬁsh are simply due
to developmental stage.
Many of the tissues containing STC-1 receptors were
transporting epithelia as beﬁtting the role of the hormone
in ion transport. Receptors were present along the entire
length of the alimentary canal, in mucosal epithelial cells
lining the buccal cavity and esophagus, and were particularly
abundant in enterocytes where STC-1 promotes luminal
HCO3− secretion [29]. Coincidently or not, high receptor
levels were also associated with the red blood cell fraction
that plays a signiﬁcant role in acid-base balance via the
Cl
−/HCO3− exchanger [30]. In the gills, another signiﬁcant
site of HCO3− e x c h a n g e ,S T C - 1r e c e p t o r sw e r em o s te v i d e n t
on cells that had the hallmarks of mitochondria-rich,
chloride cells (larger cells, individually sited, on or between
secondary lamellae). The majority of these receptors were
cytoplasmic and distinctly nonnuclear. Calcium uptake by
the gills occurs principally via epithelial channels (ECaC) on
chloride cells and pavement cells [31], and the most recent
evidence shows that STC-1 negatively regulates ECaC gene
expression as a means of attenuating gill calcium transport
[10]. Whether or not regulated calcium uptake occurs via
both cell types remains to be seen, but the present data
would indicate that STC-1 preferentially targets chloride
cells. Gill mitochondria also contained saturable, high-
aﬃnity STC-1 receptors. Most of these were undoubtedly
derived from chloride cells, which have the greatest number
of mitochondria on the respiratory epithelium as beﬁtting
their central role in ion transport. If STC-1 ultimately
proves to regulate chloride cell ECaC activity (as opposed
to only ECaC gene expression), the mechanism could very
wellinvolvethemitochondria.Inmammalianmitochondria,
STC-1 increases the mitochondrial uptake of calcium [32].
In some cell types, the underlying purpose of the eﬀect
is thought to be cytoprotective, due in part to reductions
in cytosolic calcium [27]. However, reductions in cytosolic
calcium also aﬀect cellular events such as ion transport.
In mammalian kidney, the activities of both the Na+/H+
exchanger and NaCl cotransporter require high intracellular
calciumlevelsformaximalratesoftransport[22,33].Viewed
in this light, the targeting of chloride cell mitochondria
could be the means by which STC-1 regulates ECaC
activity.
With respect to other tissues involved in mineral balance,
in situ ligand binding revealed the presence of receptors
in most nephron segments. In most instances they were
cytosolic as is the case in mammalian kidney [14, 19].
In the collecting ducts of Atlantic salmon, however, they
were more heavily concentrated along the lumen, indicative
of a role in luminal transport. Another unique feature of
Atlantic salmon collecting duct cells was in their nuclear
binding activity. Nuclear STC-1 receptors are also found on
milk-producing alveolar cells in the pregnant and lactating
rodent mammary gland [13]. Here they play critical roles
in mammary development and milk fat synthesis, both of
which are compromised by interruptions in STC-1 targeting
[17]. The prominence of nuclear receptors in the marine
ﬁsh may be indicative of a role in the renal excretion of
divalent cations. Developing nephron segments were notable
for their lack of receptors, a ﬁnding that is particularly
intriguing because they have the highest levels of STC-1 gene
expression in trout kidney [8]. This would suggest that any
ligand produced therein is destined for targeting elsewhere.
Such a target could be adjacent, more fully diﬀerentiated
nephron segments that are known to contain ligand but
little or no STC-1 transcript [8] and have only now been
shown to possess the receptor. This implies that STC-1 from
developing nephron segments could be targeted to nearby10 ISRN Endocrinology
cells in more mature tubules. This type of mesenchymal-
epithelialsignallinghasalreadybeendescribedduringmouse
nephrogenesis, whereby STC-1 from mesenchymal cells is
targeted to developing collecting duct cells [34]. The under-
lying purpose of the mammalian pathway is not understood,
and yet it is possible that a similar scenario is operative in
ﬁsh.
Intriguingly,STC-1receptorswerealsoprominentonthe
radii of scales (anterior and posterior). Presumably, they are
used as a means of tethering STC-1, as scales also contain
STC-1 immunoreactivity in a distribution pattern that is not
unlike that of its receptor (Wagner, unpublished). Scales are
an abundant source of calcium that can be mobilized by
the piscine homologues of PTH and PTHrP [35, 36]. Given
its role as an antihypercalcemic agent, STC-1 would likely
oppose the actions of both peptides.
The presence of STC-1 receptors in corpuscles of Stan-
nius cells can be interpreted in a number of ways. It could be
the means by which secreted STC-1 feeds back on the cells
of origin, similar to vasopressin feeding back on the neural
lobe to regulate its own release. Alternatively, it is possible
thatSTC-1isnormallyreleasedinatetheredstate,complexed
with a soluble form of receptor, or binding protein. At
present, there is no evidence for STC-1 binding activity
in ﬁsh blood outside the red blood cell (RBC) fraction.
However, this is not the case in mammals. In addition to
receptor-bearing RBCs, mammalian serum contains a solu-
ble binding protein that is often seen in glomerular ﬁltrates
[19].Bindingproteinscanservemanyroles,includingthatof
controlling the bioavailability of circulating ligands. Indeed,
the existence of a serum binding protein could explain why
theSTC-1inﬁshbloodundergoessuchwiderangingchanges
in its bioactivity [20]. As such, a binding protein, coreleased
in greater or lesser amounts with STC-1, could represent
an additional level of control over ligand action and/or
function.
B e c a u s et h eS T C - 1r e c e p t o rh a sy e tt ob ep u r i ﬁ e do r
cloned, its physical structure and downstream signalling
pathways are essentially unknown. There is some evidence
to suggest that the receptor is G-protein coupled. In ﬂounder
proximal tubules, the eﬀects of STC-1 on apical phosphate
transport are protein kinase A dependent (blocked by H-89
and mimicked by forskolin) and accompanied by a doubling
in cAMP output [37]. Other than this one study, however,
there is no other corroborative evidence in mammals or ﬁsh
to support the notion that the receptor is indeed G-protein
coupled. Another intriguing facet of the mammalian recep-
tor relates to its role in ligand sequestration within target
cellorganelles.Ligandsequestrationoccursinmitochondria,
nuclei, and lipid storage droplets and accounts for target
cells having such high levels of STC-1 immunoreactivity in
the absence of any measurable gene expression [2]. In the
case of mitochondria, there is an ever growing list of peptide
hormones that are sequestered therein; angiotensin II, TGF-
β, growth hormone, and atrial natriuretic peptide, to name
only some [38]. Most of the studies reporting these ﬁndings
have been done in mammals. However, the demonstration of
STC-1receptorsonﬁshmitochondrianowarguesforamuch
wider utility of this pathway among the vertebrates.
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